Bill Text: US HB4242 | 2023-2024 | 118th Congress | Introduced
Bill Title: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.
Spectrum: Slight Partisan Bill (Republican 2-1)
Status: (Introduced) 2023-06-23 - Referred to the Subcommittee on Health. [HB4242 Detail]
Download: US_Congress-2023-HB4242-Introduced.pdf